Or Yat Sun
Chief Scientific Officer
Or Yat Sun has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Feb 13, 2026.
On the most recent filing, Or Yat Sun is listed as Chief Scientific Officer at ENANTA PHARMACEUTICALS INC. Inside the rolling window, Or Yat Sun reported no open-market purchases and 1 open-market sale totaling $34K in ENTA.
Companies traded
Other insiders at ENTA
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$34K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Or Yat Sun made?
Or Yat Sun has filed 3 SEC Form 4 filings (5 transaction rows) across 1 company since 2025.
Which companies does Or Yat Sun trade?
Or Yat Sun has filed SEC Form 4 disclosures for 1 company, including ENTA.
When was Or Yat Sun's most recent SEC Form 4 filing?
Or Yat Sun's most recent SEC Form 4 filing on Tracefour is dated Feb 13, 2026.
What is Or Yat Sun's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Or Yat Sun is listed as Chief Scientific Officer.
What is Or Yat Sun's total buy and sell value in the current window?
Inside the rolling retention window, Or Yat Sun bought $0 and sold $34K based on SEC Form 4 filings.
What was Or Yat Sun's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 2,390 ENTA shares on 2025-12-05, worth $34K, per SEC Form 4 filings.